Varicella vaccination in Europe - Taking the practical approach

BMC Medicine

Volumn 7, Issue , 2009, Pages

  Bonanni, Paolo ^a   Breuer, Judith ^b   Gershon, Anne ^c   Gershon, Michael ^c   Hryniewicz, Waleria ^d   Papaevangelou, Vana ^e   Rentier, Bernard ^f   Rümke, Hans ^g   Sadzot Delvaux, Catherine ^f   Senterre, Jacques ^f   Weil Olivier, Catherine ^h   Wutzler, Peter ⁱ  

^a UNIVERSITY OF FLORENCE   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

^d NATIONAL MEDICINES INSTITUTE   (Poland)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^f UNIVERSITY OF LIÈGE   (Belgium)

^g University Vaccine Center Rotterdam Nijmegen   (Netherlands)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; MEASLES MUMPS RUBELLA VACCINE; PRIORIX TETRA; UNCLASSIFIED DRUG; VARICELLA ZOSTER VACCINE;

AGE; CHICKENPOX; CHILD DEATH; CHILD HEALTH CARE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; EUROPE; HERPES ZOSTER; HUMAN; INCIDENCE; PREGNANCY DISORDER; PUBLIC HEALTH; REVIEW; SEROPREVALENCE; TREATMENT DURATION; VACCINATION; VARICELLA ZOSTER VIRUS; IMMUNOLOGY; UTILIZATION REVIEW;

CHICKENPOX; CHICKENPOX VACCINE; EUROPE; HUMANS; VACCINATION;

EID: 67649333450     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-7-26     Document Type: Review

References (120)

1. Heininger U Seward JF Varicella Lancet 2006, 368:1365-1376. 10.1016/ S0140-6736(06)69561-5 17046469
2. World Health Organization The WHO position paper on varicella vaccines Wkly Epidemiol Rec 1998, 73:241-248. 9715106
3. Macartney KK Burgess MA Varicella vaccination in Australia and New Zealand J Infect Dis 2008, 197(Suppl 2):S191-195. 10.1086/522157 18419396
4. National Advisory Committee on Immunization National Advisory Committee on Immunization (NACI) update on varicella Can Commun Dis Rep 2004, 30:1-26.
5. Robert Koch Institut Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2006 Epidemiol Bulletin 2006, 30:235-254.
6. Childhood immunisation calendar, Greece http://www.mohaw.gr/gr/thefuture/ anakoinoseis/Timetable%202008.xls
7. WHO vaccine preventable disease monitoring system: Immunization schedules by antigen, selection centre http://www.who.int/ immunization_monitoring/en/globalsummary/scheduleselect.cfm
8. Sadzot-Delvaux C Rentier B Wutzler P Asano Y Suga S Yoshikawa T Plotkin S Varicella vaccination in Japan, South Korea, and Europe J Infect Dis 2008, 197(Suppl 2):185-190. 10.1086/522163
9. Liao SL Huang T Huang YC Jiang DD Survey of the status of self-paid varicella vaccination among children one to six years of age in Taiwan J Microbiol Immunol Infect 2007, 40:112-115. 17446958
10. Marin M Guris D Chaves SS Schmid S Seward JF Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 2007, 56:1-40. 17585291
11. Quian J Ruttimann R Romero C Dall'orso P Cerisola A Breuer T Greenberg M Verstraeten T Impact of universal varicella vaccination of one year-olds in Uruguay: 1997-2005 Arch Dis Child 2008, 93:845-850. 2563416 18456699 10.1136/adc.2007.126243
12. Perez-Farinos N Ordobas M Garcia-Fernandez C Garcia-Comas L Canellas S Rodero I Gutierrez-Rodriguez A Garcia-Gutierrez J Ramirez R Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004 BMC Infect Dis 2007, 7:59. 1913920 17570859 10.1186/ 1471-2334-7-59
13. Centers for Disease Control and Prevention Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention MMWR 1996, 45:1-36.
14. Reynolds MA Watson BM Plott-Adams KK Jumaan AO Galil K Maupin TJ Zhang JX Seward JF Epidemiology of varicella hospitalizations in the United States, 1995-2005 J Infect Dis 2008, 197(Suppl 2):S121-131.
15. Centers for Disease Control and Prevention Varicella-related deaths - United States, January 2003-June 2004 MMWR 2005, 54:272-274. 15788992
16. Centers for Disease Control and Prevention Varicella Epidemiology and Prevention of Vaccine-Preventable Diseases Washington DC: Public Health Foundation Atkinson WHJ, McIntyre L, Wolfe S 10 2006, 13:171-192.
17. Boelle PY Hanslik T Varicella in non-immune persons: Incidence, hospitalization and mortality rates Epidemiol Infect 2002, 129:599-606. 10.1017/S0950268802007720 12558344
18. Bonmarin B Ndiaye B Seringe E Levy-Bruh D Épidémiologie de la varicelle en France Bull Epidemiol Hebd 2005, 8:29-32.
19. Mallet E Maitre M Delalande-Dutilleul L Marguet C Mouterde O Evaluation of varicella complications through a retrospective hospital survey in a paediatric center over 16 years in France Arch Pediatr 2004, 11:1145-1151. 15351011
20. Liese JG Grote V Rosenfeld E Fischer R Belohradsky BH v Kries R The burden of varicella complications before the introduction of routine varicella vaccination in Germany Pediatr Infect Dis J 2008, 27:119-124. 10.1097/INF.0b013e3181586665 18227713
21. Theodoridou M Laina I Hadjichristodoulou C Syriopoulou V Varicella-related complications and hospitalisations in a tertiary pediatric medical center before vaccine introduction Eur J Pediatr 2006, 165:273-274. 10.1007/s00431-005-0043-6 16450160
22. Cameron JC Allan G Johnston F Finn A Heath PT Booy R Severe complications of chickenpox in hospitalised children in the UK and Ireland Arch Dis Child 2007, 92:1062-1066. 10.1136/adc.2007.123232 17991685
23. Marchetto S de Benedictis FM de Martino M Versace A Chiappini E Bertaine C Osimani P Cordiali R Gabiano C Galli L Epidemiology of hospital admissions for chickenpox in children: An Italian multicentre study in the pre-vaccine era Acta Paediatr 2007, 96:1490-1493. 10.1111/ j.1651-2227.2007.00465.x 17880417
24. de Melker H Berbers G Hahne S Rumke H Hof van den S de Wit A Boot H The epidemiology of varicella and herpes zoster in the Netherlands: implications for varicella zoster virus vaccination Vaccine 2006, 24:3946-3952. 10.1016/j.vaccine.2006.02.017 16564115
25. Boot H Zanden van der B van Lier A Maas van der N De Melker H Varicella zoster virus (VZV) infection The National Immunisation Programme in the Netherlands: Developments in 2007 National Institute for Public Health and the Environment de Melker H, Kramer M 2008.
26. Socan M Blasko M Surveillance of varicella and herpes zoster in Slovenia, 1996 - 2005 Euro Surveill 2007, 12.
27. Gil A Oyaguez I Carrasco P Gonzalez A Epidemiology of primary varicella hospitalizations in Spain Vaccine 2002, 20:295-298. 10.1016/ S0264-410X(01)00370-X
28. Gil A Gonzalez A Oyaguez I Martin MS Carrasco P The burden of severe varicella in Spain, 1995-2000 period Eur J Epidemiol 2004, 19:699-702. 10.1023/B:EJEP.0000036791.43264.84 15461202
29. Gil A San-Martin M Carrasco P Gonzalez A Epidemiology of severe varicella-zoster virus infection in Spain Vaccine 2004, 22:3947-3951. 10.1016/j.vaccine.2004.04.004 15364443
30. Bonhoeffer J Baer G Muehleisen B Aebi C Nadal D Schaad UB Heininger U Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents Eur J Pediatr 2005, 164:366-370. 10.1007/s00431-005-1637-8 15747132
31. Rawson H Crampin A Noah N Deaths from chickenpox in England and Wales 1995-7: Analysis of routine mortality data BMJ 2001, 323:1091-1093. 59681 11701571 10.1136/bmj.323.7321.1091
32. Dubos F Grandbastien B Hue V Martinot A Epidemiology of hospital admissions for paediatric varicella infections: A one-year prospective survey in the pre-vaccine era Epidemiol Infect 2007, 135:131-138. 10.1017/S0950268806006467 16740185
33. Emery C Lancon F Fagnani F Pechevis M Durand I Floret D ENVOL study on the medical management of varicella and its complications in French ambulatory care Med Mal Infect 2006, 36:92-98. 16460897
34. Grimprel E Levy C de La Rocque F Cohen R Soubeyrand B Caulin E Derrough T Lecuyer A d'Athis P Gaudelus J Paediatric varicella hospitalisations in France: A nationwide survey Clin Microbiol Infect 2007, 13:546-549. 10.1111/j.1469-0691.2007.01706.x 17378927
35. Wagenpfeil S Neiss A Banz K Wutzler P Empirical data on the varicella situation in Germany for vaccination decisions Clin Microbiol Infect 2004, 10:425-430. 10.1111/j.1469-0691.2004.00853.x 15113320
36. Ziebold C von Kries R Lang R Weigl J Schmitt HJ Severe complications of varicella in previously healthy children in Germany: A 1-year survey Pediatrics 2001, 108:E79. 10.1542/peds.108.1.79 11694663
37. Katsafadou A Ferentinos G Constantopoulos A Papaevangelou V The epidemiology of varicella in school-aged Greek children before the implementation of universal vaccination Eur J Clin Microbiol Infect Dis 2008, 27:223-226. 10.1007/s10096-007-0418-x 18026762
38. Ciofi Degli Atti ML Salmaso S Bella A Arigliani R Gangemi M Chiamenti G Brusoni G Tozzi AE Pediatric sentinel surveillance of vaccine-preventable diseases in Italy Pediatr Infect Dis J 2002, 21:763-768. 10.1097/00006454-200208000-00013 12192166
39. Reports on cases of infectious diseases and poisonings in Poland - 2006 http://www.pzh.gov.pl/oldpage/epimeld/2006/index_ma.html
40. Arama V Rafila A Streinu-Cercel A Pistol A Bacruban R Sandu R Pitigoi D Negoita A Varicella in Romania: Epidemiological trends, 1986-2004 Euro Surveill 2005, 10:E050811-050816. 16785684
41. Diez-Domingo J Aristegui J Calbo F Gonzalez-Hachero J Moraga F Pena Guitian J Ruiz Contreras J Torrellas A Epidemiology and economic impact of varicella in immunocompetent children in Spain. A nation-wide study Vaccine 2003, 21:3236-3239. 10.1016/S0264-410X(03)00264-0 12804853
42. Perez-Yarza EG Arranz L Alustiza J Azkunaga B Uriz J Sarasua A Mendiburu I Emparanza JI Hospital admissions for varicella complications in children aged less than 15 years old An Pediatr (Barc) 2003, 59:229-233. 10.1157/13050601 12975114
43. Brisson M Edmunds WJ Epidemiology of varicella-zoster virus in England and Wales J Med Virol 2003, 70(Suppl 1):S9-14. 10.1002/jmv.10313 12627480
44. Nardone A de Ory F Carton M Cohen D van Damme P Davidkin I Rota MC de Melker H Mossong J Slacikova M Tischer A Andrews N Berbers G Gabutti G Gay N Jones L Jokinen S Kafatos G de Aragon MV Schneider F Smetana Z Vargova B Vranckx R Miller E The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region Vaccine 2007, 25:7866-7872. 10.1016/j.vaccine.2007.07.036 17919788
45. Aebi C Fischer K Gorgievski M Matter L Muhlemann K Age-specific seroprevalence to varicella-zoster virus: Study in Swiss children and analysis of European data Vaccine 2001, 19:3097-3103. 10.1016/ S0264-410X(01)00035-4 11312004
46. Mossong J Putz L Schneider F Seroprevalence and force of infection of varicella-zoster virus in Luxembourg Epidemiol Infect 2004, 132:1121-1127. 10.1017/S0950268804002754 15635970
47. Salleras L Dominguez A Vidal J Plans P Salleras M Taberner JL Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes Vaccine 2000, 19:183-188. 10.1016/S0264-410X(00)00178-X 10930671
48. Thiry N Beutels P Shkedy Z Vranckx R Vandermeulen C Wielen MV Damme PV The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium) Eur J Pediatr 2002, 161:588-593. 10.1007/ s00431-002-1053-2 12424583
49. Wutzler P Farber I Wagenpfeil S Bisanz H Tischer A Seroprevalence of varicella-zoster virus in the German population Vaccine 2001, 20:121-124. 10.1016/S0264-410X(01)00276-6 11567755
50. Alp H Altinkaynak S Ertekin V Kilicaslan B Giiraksin A Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey Health Policy 2005, 72:119-124. 10.1016/ j.healthpol.2004.03.008 15760704
51. Gabutti G Penna C Rossi M Salmaso S Rota MC Bella A Crovari P The seroepidemiology of varicella in Italy Epidemiol Infect 2001 126 433 440 10.1017/S0950268801005398 11467800
52. Katsafadou A Kallergi K Ferentinos G Goulioti T Foustoukou M Papaevangelou V Presumptive varicella vaccination is warranted in Greek adolescents lacking a history of disease or household exposure Eur J Pediatr 2009, 168:23-25. 10.1007/s00431-008-0701-6 18392640
53. Khoshnood B Debruyne M Lancon F Emery C Fagnani F Durand I Floret D Seroprevalence of varicella in the French population Pediatr Infect Dis J 2006, 25:41-44. 10.1097/01.inf.0000195636.43584.bb 16395101
54. Garnett GP Cox MJ Bundy DA Didier JM St Catharine J The age of infection with varicella-zoster virus in St Lucia, West Indies Epidemiol Infect 1993, 110:361-372. 8386097
55. Brisson M Edmunds WJ Law B Gay NJ Walld R Brownell M Roos L De Serres G Epidemiology of varicella zoster virus infection in Canada and the United Kingdom Epidemiol Infect 2001, 127:305-314. 10.1017/ S0950268801005921 11693508
56. Kudesia G Partridge S Farrington CP Soltanpoor N Changes in age-related seroprevalence of antibody to varicella zoster virus: Impact on vaccine strategy J Clin Pathol 2002, 55:154-155. 1769589 11865016
57. Deguen S Chau NP Flahault A Epidemiology of chickenpox in France (1991-1995) J Epidemiol Community Health 1998, 52(Suppl 1):S46-49.
58. Yawn B Saddier P Wollan P St Sauver J Kurland M Sy L A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction Mayo Clin Proc 2007, 82:1341-1349. 10.4065/ 82.11.1341 17976353
59. Menson E Heath PT Lyall H Ramsay M Sinka K Miles J Fleming T Tong W Breuer J Nyman AG 2006-7 chickenpox season: 13 childhood deaths in England, Scotland and Wales compared with averages of 4-8.7 per year in the United Kingdom: More evidence for routine introduction of the varicella vaccine? Arch Dis Child 2008, 93(Suppl 1):A75-84.
60. Grote V von Kries R Springer W Hammersen G Kreth HW Liese J Varicella-related deaths in children and adolescents - Germany 2003-2004 Acta Paediatr 2008, 97:187-192. 10.1111/j.1651-2227.2007.00595.x 18076716
61. Meyer PA Seward JF Jumaan AO Wharton M Varicella mortality: Trends before vaccine licensure in the United States, 1970-1994 J Infect Dis 2000, 182:383-390. 10.1086/315714 10915066
62. Miller E Marshall R Epidemiology, outcome and control of varicella-zoster infection Rev Med Microbiol 1993, 4:222-230.
63. Mohsen AH McKendrick M Varicella pneumonia in adults Eur Respir J 2003, 21:886-891. 10.1183/09031936.03.00103202 12765439
64. Sauerbrei A Wutzler P The congenital varicella syndrome J Perinatol 2000, 20:548-554. 10.1038/sj.jp.7200457 11190597
65. Sauerbrei A Wutzler P Neonatal varicella J Perinatol 2001, 21:545-549. 10.1038/sj.jp.7210599 11774017
66. Sauerbrei A Wutzler P Varicella-zoster virus infections during pregnancy: Epidemiology, clinical symptoms, diagnosis, prevention and therapy Curr Pediat Rev 2005, 1:205-216. 10.2174/157339605774574962
67. Thomas SL Hall AJ What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 2004, 4:26-33. 10.1016/ S1473-3099(03)00857-0 14720565
68. Schmader K Gnann JW Watson P The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine J Infect Dis 2008, 197(Suppl 2):S207-215. 10.1086/522152 18419399
69. Grote V von Kries R Rosenfeld E Belohradsky BH Liese J Immunocompetent children account for the majority of complications in childhood herpes zoster J Infect Dis 2007, 196:1455-1458. 10.1086/522631 18008223
70. Scott FT Johnson RW Leedham-Green M Davies E Edmunds WJ Breuer J The burden of herpes zoster: A prospective population based study Vaccine 2006, 24:1308-1314. 10.1016/j.vaccine.2005.09.026 16352376
71. Chidiac C Bruxelle J Daures JP Hoang-Xuan T Morel P Leplege A El Hasnaoui A de Labareyre C Characteristics of patients with herpes zoster on presentation to practitioners in France Clin Infect Dis 2001, 33:62-69. 10.1086/320884 11389496
72. Davies L Cossins L Bowsher D Drummond M The cost of treatment for post-herpetic neuralgia in the UK Pharmacoeconomics 1994, 6:142-148. 10.2165/00019053-199406020-00006 10147439
73. Varicella vaccination overview in European countries http://www.euvac.net/graphics/euvac/vaccination/var.html
74. Sengupta N Booy R Schmitt HJ Peltola H Van-Damme P Schumacher RF Campins M Rodrigo C Heikkinen T Seward J Jumaan A Finn A Olcen P Thiry N Weil-Olivier C Breuer J Varicella vaccination in Europe: Are we ready for a universal childhood programme? Eur J Pediatr 2008, 167:47-55. 10.1007/s00431-007-0424-0 17334784
75. Wutzler P Schmitt H-J Bisanz H Soziale Pädiatrie und Jugendmedizin Kinderärztliche Praxis 2008, 79:75-77.
76. Robert Koch Institut Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2007 Epidemiol Bull 2007, 30:267-286.
77. Siedler A Arndt U Varicella sentinel in Germany shows success of vaccination 26th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID); 13-17 May; Graz, Austria 2008.
78. Banz K Wagenpfeil S Neiss A Goertz A Staginnus U Vollmar J Wutzler P The cost-effectiveness of routine childhood varicella vaccination in Germany Vaccine 2003, 21:1256-1267. 10.1016/S0264-410X(02)00431-0 12559807
79. Knuf M Neiss A Wutzler P Impact of universal varicella vaccination in Germany: An epidemiological and economic analysis Klin Padiatr 2006, 218:203-212. 10.1055/s-2005-836610 16819701
80. Rentier B Gershon AA the members of EuroVar the European Working Group on Varicella (EuroVar) A consensus paper: Varicella vaccination of healthy children - a challenge for Europe Pediatr Infect Dis J 2004, 23:379-389. 10.1097/01.inf.0000122606.88429.8f 15131459
81. Ramet J Weil-Olivier C Sedlak W Is Europe ready to embrace a policy of universal varicella vaccination? Int J Clin Pract 2005, 59:1326-1333. 10.1111/j.1742-1241.2005.00647.x 16236088
82. Knuf M Habermehl P Zepp F Mannhardt W Kuttnig M Muttonen P Prieler A Maurer H Bisanz H Tornieporth N Descamps D Willems P Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children Pediatr Infect Dis J 2006, 25:12-18. 10.1097/ 01.inf.0000195626.35239.58 16395096
83. Kuter BJ Brown ML Hartzel J Williams WR EvesiKaren A Black S Shinefield H Reisinger KS Marchant CD Sullivan BJ Thear M Klopfer S Xu J Gress JO Schodel F Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad) Hum Vaccin 2006, 2:205-214. 17035730
84. Reynolds MA Chaves SS Harpaz R AS L Seward JF The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: A review J Infect Dis 2008, 197(Suppl 2):S224-227. 10.1086/522162 18419401
85. Nguyen HQ Jumaan AO Seward JF Decline in mortality due to varicella after implementation of varicella vaccination in the United States N Engl J Med 2005, 352:450-458. 10.1056/NEJMoa042271 15689583
86. Banz K Wagenpfeil S Neiss A Hammerschmidt T Wutzler P The burden of varicella in Germany: Potential risks and economic impact Eur J Health Econom 2004, 5:46-53. 10.1007/s10198-003-0200-7
87. McCauley MM Stokley S Stevenson J Fishbein DB Adolescent vaccination: coverage achieved by ages 13-15 years, and vaccinations received as recommended during ages 11-12 years, National Health Interview Survey 1997-2003 J Adolesc Health 2008, 43:540-547. 10.1016/ j.jadohealth.2008.08.002 19027641
88. Wutzler P Neiss A Banz K Goertz A Bisanz H Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany Med Microbiol Immunol (Berl) 2002, 191:89-96. 10.1007/s00430-002-0123-4
89. Seward JF Watson BM Peterson CL Mascola L Pelosi JW Zhang JX Maupin TJ Goldman GS Tabony LJ Brodovicz KG Jumaan AO Wharton M Varicella disease after introduction of varicella vaccine in the United States, 1995-2000 JAMA 2002, 287:606-611. 10.1001/jama.287.5.606 11829699
90. Zhou F Harpaz R Jumaan AO Winston CA Shefer A Impact of varicella vaccination on health care utilization JAMA 2005, 294:797-802. 10.1001/ jama.294.7.797 16106004
91. Centers for Disease Control and Prevention Update: Recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine MMWR 2008, 57:258-260. 18340332
92. Department of Health and Human Services Centers for Disease Control and Prevention Advisory Committee on Immunization Practices Summary report, 27-28 February 2008 http://www.cdc.gov/vaccines/recs/ACIP/downloads/ min-feb08.pdf
93. FDA: Information pertaining to labeling revision for ProQuad http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ ucm123798.htm
94. Reisinger KS Brown ML Xu J Sullivan BJ Marshall GS Nauert B Matson DO Silas PE Schodel F Gress JO Kuter BJ A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax Pediatrics 2006, 117:265-272. 10.1542/peds.2005-0092 16452343
95. Halperin S Guiseppe F Scheifele D Gerard P Guiseppe S Cuccia M Willems P Immunogenicity and safety of measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age 25th International Congress of Paediatrics (ICP); 25-30 August; Athens, Greece 2007.
96. European Medicines Agency: ProQuad summary of product characteristics, 11 September 2008. http://www.emea.europa.eu/humandocs/PDFs/EPAR/proquad/ 062206en6.pdf
97. Bernaola Iturbe E Gimenez Sanchez F Baca Cots M de Juan Martin F Diez Domingo J Garces Sanchez M Gomez-Campdera A Martinon-Torres F Picazo JJ Pineda Solas V Vaccination schedule of the Spanish Association of Pediatrics: Recommendations 2007 An Pediatr (Barc) 2007, 66:62-69. 17266854
98. Sosa LE Hadler JL Epidemiology of varicella in Connecticut, 2001-2005 J Infect Dis 2008, 197(Suppl 2):S90-93. 10.1086/522128 18419416
99. Seward J Marin M Vazquez M Varicella vaccine effectiveness in the US vaccination program: A review J Infect Dis 2008, 197:S82-87. 10.1086/ 522145 18419415
100. Chaves SS Gargiullo P Zhang JX Civen R Guris D Mascola L Seward JF Loss of vaccine-induced immunity to varicella over time N Engl J Med 2007, 356:1121-1129. 10.1056/NEJMoa064040 17360990
101. Kuter B Matthews H Shinefield H Black S Dennehy P Watson B Reisinger K Kim LL Lupinacci L Hartzel J Chan I Ten year follow-up of healthy children who received one or two injections of varicella vaccine Pediatr Infect Dis J 2004, 23:132-137. 10.1097/01.inf.0000109287.97518.67 14872179
102. Nader S Bergen R Sharp M Arvin AM Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine J Infect Dis 1995, 171:13-17. 7798653
103. Watson B Boardman C Laufer D Piercy S Tustin N Olaleye D Cnaan A Starr SE Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine Clin Infect Dis 1995, 20:316-319. 7742436
104. MMR vaccination overview in European countries http://www.euvac.net/ graphics/euvac/vaccination/mmr.html
105. World Health Organization Measles vaccines Wkly Epidemiol Rec 2004, 79:130-142. 15114951
106. Zepp F Manegold-Randel D Helm K Gildberg P Knuf M de la Bourdonnaye G Willems P Antibody persistence and varicella breakthrough case assessment three years after administration of measles-mumps-rubella-varicella (MMRV) vaccine in children aged 11-23 months 26th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID); 13-17 May; Graz, Austria 2008.
107. Peltola H Heinonen OP Valle M Paunio M Virtanen M Karanko V Cantell K The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program N Engl J Med 1994, 331:1397-1402. 10.1056/NEJM199411243312101 7969278
108. Vesikari T Baer G Willems P Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella (MMRV) vaccine in healthy children aged 5-6 years Pediatr Infect Dis J 2007, 26:153-158. 10.1097/ 01.inf.0000250689.09396.21 17259879
109. Jumaan AO Yu O Jackson LA Bohlke K Galil K Seward JF Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002 J Infect Dis 2005, 191:2002-2007. 10.1086/430325 15897984
110. Brisson M Gay NJ Edmunds WJ Andrews NJ Exposure to varicella boosts immunity to herpes-zoster: Implications for mass vaccination against chickenpox Vaccine 2002, 20:2500-2507. 10.1016/S0264-410X(02)00180-9 12057605
111. Thomas SL Wheeler JG Hall AJ Contacts with varicella or with children and protection against herpes zoster in adults: A case-control study Lancet 2002, 360:678-682. 10.1016/S0140-6736(02)09837-9 12241874
112. Insinga RP Itzler RF Pellissier JM Saddier P Nikas AA The incidence of herpes zoster in a United States administrative database J Gen Intern Med 2005, 20:748-753. 1490195 16050886 10.1111/j.1525-1497.2005.0150.x
113. Hambleton S Steinberg SP LaRussa PS Shapiro ED Gershon AA Risk of herpes zoster in adults immmunized with varicella vaccine J Infect Dis 2008, 197(Suppl 2):S196-199. 10.1086/522131 18419397
114. Hardy I Gershon AA Steinberg SP LaRussa P The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group N Engl J Med 1991, 325:1545-1550. 1658650
115. Gershon AA Chen J Gershon MD A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neurons J Infect Dis 2008, 197(Suppl 2):S61-65. 10.1086/522149 18419411
116. Son M Shapiro E LaRussa P Neu N Michalik D Meglin M Bitar W Jurgrau A Flynn P Gershon A Vaccination of children with perinatal HIV infection protects against varicella and zoster Pediatric Academic Societies' Annual Meeting; 2-6 May; Honolulu, Hawaii 2008.
117. Vaccination coverage for measles containing vaccines http://data.euro.who.int/cisid/
118. Hammerschmidt T Bisanz H Wutzler P Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: An economic analysis Vaccine 2007, 25:7307-7312. 10.1016/ j.vaccine.2007.08.017 17881097
119. Bonanni P Boccalini S Bechini A Banz K Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: The burden of uncomplicated hospitalised cases Vaccine 2008, 26:5619-5626. 10.1016/j.vaccine.2008.07.096 18723062
120. Zhou F IR O-S Guris D Shefer A Lieu T Seward JF An economic analysis of the universal varicella vaccination program in the United States J Infect Dis 2008, 197(Suppl 2):S156-164. 10.1086/522135 18419391